JARGLYXI
(Based on 44(d) Priority Application) Pharmaceutical preparations for the treatment of metabolic and cardiovascular diseases(Based on 44(e)) Pharmaceutical preparations for the treatment of metabolic and cardiovascular diseases
Cancelled · June 5, 2018 · 87949050 ·